Communication
RSC Advances
J.
Muhlbacher,
K.
Schaumann,
S.
Sudarsono,
G. Bringmann and P. Proksch, J. Nat. Prod., 2002, 65, 1598–
1604.
3 A. S. Khartulyari, M. Kapur and M. E. Maier, Org. Lett., 2006,
25, 5833–5836.
4 (a) P. H. Hidy, R. S. Baldwin, R. L. Greasham, C. L. Keith and
J. R. McMullen, Adv. Appl. Microbiol., 1977, 22, 59–82; (b)
J. W. Bennett and M. Klich, Clin. Microbiol. Rev., 2003, 16,
497–516.
5 A. Dombrowski, R. Jenkins, S. Raghoobar, G. Bills,
J. Polishook, F. Pelaez, B. Burgess, A. Zhao, L. Huang,
Y. Zhang and M. Goetz, J. Antibiot., 1999, 52, 1077–1088.
6 (a) Y. L. Janin, J. Med. Chem., 2005, 48, 7503–7512; (b)
T. J. Turbyville, E. M. K. Wijeratne, M. X. Liu, A. M. Burns,
C. J. Seliga, L. A. Luevano, C. L. David, S. H. Faeth, L. Whitesell
and A. A. L. Gunatilaka, J. Nat. Prod., 2006, 69, 178–184.
7 (a) G. Lukacs and M. Ohno, Recent Progress in the Chemical
Synthesis of Antibiotics, Springer-Verlag, Berlin, 1990; (b)
S. Omura, Macrolide Antibiotics, Academic Press, 2nd edn,
1984, 301–347.
8 (a) E. J. Corey and K. C. Nicolaou, J. Am. Chem. Soc., 1974, 96,
5614–5616; (b) E. J. Corey, D. J. Brunelle and P. J. Stork,
Tetrahedron Lett., 1976, 17, 3405–3408.
9 (a) S. Masamune, M. Hirama, S. Mori, S. A. Ali and D. S. Garvey,
J. Am. Chem. Soc., 1981, 103, 1568–1571; (b) S. Masamune,
C. U. Kim, K. E. Wilson, G. O. Spessard, P. E. Georghiou and
G. S. Bates, J. Am. Chem. Soc., 1975, 97, 3512–3513.
10 (a) T. Mukaiyama, M. Usui, E. Shimada and K. Saigo, Chem.
Lett., 1975, 1045–1048; (b) T. Mukaiyama, M. Usui and
K. Saigo, Chem. Lett., 1976, 49–50.
11 J. Inanaga, T. Katsuki, S. Takimoto, S. Ouchida, K. Inoue,
A. Nakano, N. Okukado and M. Yamaguchi, Chem. Lett.,
1979, 1021–1024.
12 (a) E. P. Boden and G. E. Keck, J. Org. Chem., 1985, 50, 2394–
2395; (b) B. Neises and W. Steglich, Angew. Chem., Int. Ed.
Engl., 1978, 17, 522–524.
Scheme 6 Synthesis of benzolactone 20 using the present methodology.
a rotary evaporator attached to an efficient vacuum pump.
Products obtained as solids or syrups were dried under high
vacuum. Solvents used were mainly of LR grade and for reac-
tions dry solvents were used purchased from Sigma Aldrich.
Optical rotation measurements were carried out on Perkin-
Elmer 241 polarimeter.
Typical procedure for cyclization via intramolecular
Sonogashira reaction: synthesis of compound VIII
The cyclization precursor 10 containing alkynyl group and aryl
halide moiety (100 mg, 0.24 mmol) was dissolved in dry THF
(3.0 mL). Heterogeneous Pd-catalyst R (reported in our previous
paper ref. 29) containing basic support (100 wt%) and co-cata-
lyst CuI (5 mol%) were added to the above solution and the
reaction mixture was allowed to stir for several hours at room
temperature under nitrogen environment. Aer ascertaining
completion of the reaction by TLC, the catalyst was ltered and
the solvent was evaporated under vacuum. The reaction mixture
was extracted with ethyl acetate and dried over anhydrous
Na2SO4. Aer evaporation, the product was puried by column
chromatography on silica gel using petroleum ether–ethyl
acetate as the eluent to obtain the pure product VIII as a thick
liquid (72.3 mg, 90%); Rf (45% EtOAc/hexane) 0.50; [a]2D5 ꢁ1.30ꢀ
(c 1.0, CHCl3); IR (CHCl3) 2980, 2938, 2210, 1733, 1588 cmꢁ1; 1H
NMR (400 MHz, CDCl3) d 7.84 (dd, J ¼ 7.4, 2.0 Hz, 1H), 7.66 (dd,
J ¼ 7.7, 1.2 Hz, 1H), 7.44–7.27 (m, 2H), 5.96 (d, J ¼ 3.7 Hz, 1H),
4.63 (d, J ¼ 3.7 Hz, 1H), 4.62–4.58 (m, 1H), 4.56 (dd, J ¼ 7.0, 3.6
Hz, 1H), 4.50 (dd, J ¼ 10.1, 6.0 Hz, 1H), 4.35 (d, J ¼ 16.5 Hz, 1H),
4.30 (d, J ¼ 16.5 Hz, 1H), 4.18 (d, J ¼ 2.9 Hz, 1H), 1.51 (s, 3H),
1.34 (s, 3H); 13C NMR (125 MHz, CDCl3) d 165.7, 134.4, 132.7,
131.7, 131.6, 127.2, 121.9, 112.1, 105.2, 81.9, 81.7, 76.8, 74.8,
70.9, 62.9, 57.9, 26.8, 26.3; ESI MS (m/z): 330 [M+]; Anal. calcd for
13 T. Kurihara, Y. Nakajima and O. Mitsunobu, Tetrahedron
Lett., 1976, 17, 2455–2458.
14 (a) I. Shiina, Tetrahedron, 2004, 60, 1587–1599; (b) I. Shiina
and T. Mukaiyama, Chem. Lett., 1994, 677–680.
¨
15 A. Furstner and K. J. Langemann, J. Org. Chem., 1996, 61,
C
18H18O6: C, 65.45; H, 5.49. Found C, 65.35; H, 5.38%.
3942–3943.
¨
¨
16 A. Furstner and T. Muller, Synlett, 1997, 1010–1012.
17 R. Hili, V. Rai and A. K. Yudin, J. Am. Chem. Soc., 2010, 132,
2889–2891.
Acknowledgements
Authors are thankful to director Indian Institute of Integrative
Medicine (CSIR-IIIM, Jammu) for providing necessary facilities
and DST for nancial support (Project GAP1145). A.H. is
thankful to UGC (New Delhi) for Fellowship (SRF).
18 C. M. Madsen, M. Hansen, V. Thrane and M. H. Clausen,
Tetrahedron, 2010, 66, 9849–9859.
19 M. J. Wingstrand, C. M. Madsen and M. H. Clausen,
Tetrahedron Lett., 2009, 50, 693–695.
20 S. E. Denmark and J. M. Muhuhi, J. Am. Chem. Soc., 2010,
132, 11768–11778.
References
1 M. I. Konaklieva and B. J. Plotkin, Mini-Rev. Med. Chem., 21 J. Krauss, D. Unterreitmeier, C. Neudert and F. Bracher, Arch.
2005, 5, 73–95. Pharm. Chem. Life Sci., 2005, 338, 605–608.
2 (a) Macrolide Antibiotics: Chemistry, Biology, and Practice, ed. 22 V. Balraju, D. S. Reddy, M. Periasamy and J. Iqbal, J. Org.
S. Omura, Academic Press, San Diego, 2nd edn, 2002. Chem., 2005, 70, 9626–9628.
Xestodecalactone A: (b) R. A. Edrada, M. Heubes, 23 Y. Koyama, M. J. Lear, F. Yoshimura, I. Ohashi, T. Mashimo
G. Brauers, V. Wray, A. Berg, U. Grafe, M. Wohlfarth,
and M. Hirama, Org. Lett., 2005, 7, 267–270.
This journal is ª The Royal Society of Chemistry 2013
RSC Adv., 2013, 3, 19899–19904 | 19903